EU HTA Publication Digest: Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Dang et al. reviewed the implementation of Joint Clinical Assessments under the EU HTAR (Regulation 2021/2282), analyzing methodological, regulatory, and stakeholder implications across EU Member States. The authors examined how the harmonized PICO framework, tight timelines, and national HTA and reimbursement autonomy may shape evidence generation and market access. They highlight persistent misalignment between EU-level assessments and national HTA processes, underscoring the need for adaptive approaches and early stakeholder engagement to prevent delays and uncertainty in reimbursement decisions.

Access the full-text article here.